Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Plasma Lipidome Analysis by Liquid Chromatography-High Resolution Mass Spectrometry and Ion Mobility of Hypertriglyceridemic Patients on Extended-Release Nicotinic Acid: a Pilot Study.

Ferchaud-Roucher V, Croyal M, Moyon T, Zair Y, Krempf M, Ouguerram K.

Cardiovasc Drugs Ther. 2017 Jun;31(3):269-279. doi: 10.1007/s10557-017-6737-y.

PMID:
28752209
2.

Multiplexed peptide analysis for kinetic measurements of major human apolipoproteins by LC/MS/MS.

Croyal M, Fall F, Ferchaud-Roucher V, Chétiveaux M, Zaïr Y, Ouguerram K, Krempf M, Nobécourt E.

J Lipid Res. 2016 Mar;57(3):509-15. doi: 10.1194/jlr.D064618. Epub 2016 Jan 15.

3.

Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody.

Hopkins PN, Defesche J, Fouchier SW, Bruckert E, Luc G, Cariou B, Sjouke B, Leren TP, Harada-Shiba M, Mabuchi H, Rabès JP, Carrié A, van Heyningen C, Carreau V, Farnier M, Teoh YP, Bourbon M, Kawashiri MA, Nohara A, Soran H, Marais AD, Tada H, Abifadel M, Boileau C, Chanu B, Katsuda S, Kishimoto I, Lambert G, Makino H, Miyamoto Y, Pichelin M, Yagi K, Yamagishi M, Zair Y, Mellis S, Yancopoulos GD, Stahl N, Mendoza J, Du Y, Hamon S, Krempf M, Swergold GD.

Circ Cardiovasc Genet. 2015 Dec;8(6):823-31. doi: 10.1161/CIRCGENETICS.115.001129. Epub 2015 Sep 15.

4.

Laparoscopic Gastric Banding in Obese Patients with Sleep Apnea: A 3-Year Controlled Study and Follow-up After 10 Years.

Feigel-Guiller B, Drui D, Dimet J, Zair Y, Le Bras M, Fuertes-Zamorano N, Cariou B, Letessier E, Nobécourt-Dupuy E, Krempf M.

Obes Surg. 2015 Oct;25(10):1886-92. doi: 10.1007/s11695-015-1627-5.

PMID:
25702144
5.

Effect of a high bicarbonate mineral water on fasting and postprandial lipemia in moderately hypercholesterolemic subjects: a pilot study.

Zair Y, Kasbi-Chadli F, Housez B, Pichelin M, Cazaubiel M, Raoux F, Ouguerram K.

Lipids Health Dis. 2013 Jul 18;12:105. doi: 10.1186/1476-511X-12-105.

6.

A combined natural supplement lowers LDL cholesterol in subjects with moderate untreated hypercholesterolemia: a randomized placebo-controlled trial.

Barrat E, Zaïr Y, Ogier N, Housez B, Vergara C, Maudet C, Lescuyer JF, Bard JM, Carpentier YA, Cazaubiel M, Peltier SL.

Int J Food Sci Nutr. 2013 Nov;64(7):882-9. doi: 10.3109/09637486.2013.809405. Epub 2013 Jul 2.

PMID:
23815518
7.

Dual peroxisome proliferator-activated receptor α/δ agonist GFT505 improves hepatic and peripheral insulin sensitivity in abdominally obese subjects.

Cariou B, Hanf R, Lambert-Porcheron S, Zaïr Y, Sauvinet V, Noël B, Flet L, Vidal H, Staels B, Laville M.

Diabetes Care. 2013 Oct;36(10):2923-30. doi: 10.2337/dc12-2012. Epub 2013 May 28.

8.

Plasma PCSK9 concentrations during an oral fat load and after short term high-fat, high-fat high-protein and high-fructose diets.

Cariou B, Langhi C, Le Bras M, Bortolotti M, Lê KA, Theytaz F, Le May C, Guyomarc'h-Delasalle B, Zaïr Y, Kreis R, Boesch C, Krempf M, Tappy L, Costet P.

Nutr Metab (Lond). 2013 Jan 8;10(1):4. doi: 10.1186/1743-7075-10-4.

9.

Effect on LDL-cholesterol of a large dose of a dietary supplement with plant extracts in subjects with untreated moderate hypercholesterolaemia: a randomised, double-blind, placebo-controlled study.

Barrat E, Zaïr Y, Sirvent P, Chauveau P, Maudet C, Housez B, Derbord E, Lescuyer JF, Bard JM, Cazaubiel M, Peltier SL.

Eur J Nutr. 2013 Dec;52(8):1843-52. doi: 10.1007/s00394-012-0486-2. Epub 2012 Dec 25.

PMID:
23266743
10.

Low rate of production of apolipoproteins B100 and AI in 2 patients with Anderson disease (chylomicron retention disease).

Ouguerram K, Zaïr Y, Kasbi-Chadli F, Nazih H, Bligny D, Schmitz J, Aparicio T, Chétiveaux M, Magot T, Aggerbeck LP, Samson-Bouma ME, Krempf M.

Arterioscler Thromb Vasc Biol. 2012 Jun;32(6):1520-5. doi: 10.1161/ATVBAHA.112.245076. Epub 2012 Mar 22.

PMID:
22441101
11.
12.

Fasting plasma chenodeoxycholic acid and cholic acid concentrations are inversely correlated with insulin sensitivity in adults.

Cariou B, Chetiveaux M, Zaïr Y, Pouteau E, Disse E, Guyomarc'h-Delasalle B, Laville M, Krempf M.

Nutr Metab (Lond). 2011 Jul 7;8(1):48. doi: 10.1186/1743-7075-8-48.

13.

Comparative pharmacodynamic and pharmacokinetic characteristics of subcutaneous insulin glulisine and insulin aspart prior to a standard meal in obese subjects with type 2 diabetes.

Bolli GB, Luzio S, Marzotti S, Porcellati F, Sert-Langeron C, Charbonnel B, Zair Y, Owens DR.

Diabetes Obes Metab. 2011 Mar;13(3):251-7. doi: 10.1111/j.1463-1326.2010.01343.x.

14.

Acetogenic fibers reduce fasting glucose turnover but not peripheral insulin resistance in metabolic syndrome patients.

Pouteau E, Ferchaud-Roucher V, Zair Y, Paintin M, Enslen M, Auriou N, Macé K, Godin JP, Ballèvre O, Krempf M.

Clin Nutr. 2010 Dec;29(6):801-7. doi: 10.1016/j.clnu.2010.05.006. Epub 2010 Jul 2.

PMID:
20584565
15.

A fourth locus for autosomal dominant hypercholesterolemia maps at 16q22.1.

Marques-Pinheiro A, Marduel M, Rabès JP, Devillers M, Villéger L, Allard D, Weissenbach J, Guerin M, Zair Y, Erlich D, Junien C, Munnich A, Krempf M, Abifadel M, Jaïs JP; French Research Network on ADH, Boileau C, Varret M.

Eur J Hum Genet. 2010 Nov;18(11):1236-42. doi: 10.1038/ejhg.2010.94. Epub 2010 Jun 23.

16.

PCSK9 dominant negative mutant results in increased LDL catabolic rate and familial hypobetalipoproteinemia.

Cariou B, Ouguerram K, Zaïr Y, Guerois R, Langhi C, Kourimate S, Benoit I, Le May C, Gayet C, Belabbas K, Dufernez F, Chétiveaux M, Tarugi P, Krempf M, Benlian P, Costet P.

Arterioscler Thromb Vasc Biol. 2009 Dec;29(12):2191-7. doi: 10.1161/ATVBAHA.109.194191. Epub 2009 Sep 17.

PMID:
19762784
17.

Disturbance of apolipoprotein B100 containing lipoprotein metabolism in severe hyperlipidemic and lipodystrophic HIV patients on combined antiretroviral therapy: evidences of insulin resistance effect.

Ouguerram K, Zair Y, Billon S, Chétiveaux M, Brunet-François C, Ngohou-Bach K, Allavena C, Reliquet V, Milpied B, Magot T, Raffi F, Krempf M.

Med Chem. 2008 Nov;4(6):544-50.

PMID:
18991738
18.

Dual mechanisms for the fibrate-mediated repression of proprotein convertase subtilisin/kexin type 9.

Kourimate S, Le May C, Langhi C, Jarnoux AL, Ouguerram K, Zaïr Y, Nguyen P, Krempf M, Cariou B, Costet P.

J Biol Chem. 2008 Apr 11;283(15):9666-73. doi: 10.1074/jbc.M705831200. Epub 2008 Feb 3.

19.

Kinetics of prebeta1 HDL and alphaHDL in type II diabetic patients.

Chétiveaux M, Lalanne F, Lambert G, Zair Y, Ouguerram K, Krempf M.

Eur J Clin Invest. 2006 Jan;36(1):29-34.

PMID:
16403007
20.

Colonic fermentation from lactulose inhibits lipolysis in overweight subjects.

Ferchaud-Roucher V, Pouteau E, Piloquet H, Zaïr Y, Krempf M.

Am J Physiol Endocrinol Metab. 2005 Oct;289(4):E716-20.

21.

Influence of atorvastatin on apolipoprotein E and AI kinetics in patients with type 2 diabetes.

Bach-Ngohou K, Ouguerram K, Frénais R, Maugère P, Ripolles-Piquer B, Zaïr Y, Krempf M, Bard JM.

J Pharmacol Exp Ther. 2005 Oct;315(1):363-9. Epub 2005 Jul 13.

PMID:
16014756
22.

Wild-type PCSK9 inhibits LDL clearance but does not affect apoB-containing lipoprotein production in mouse and cultured cells.

Lalanne F, Lambert G, Amar MJ, Chétiveaux M, Zaïr Y, Jarnoux AL, Ouguerram K, Friburg J, Seidah NG, Brewer HB Jr, Krempf M, Costet P.

J Lipid Res. 2005 Jun;46(6):1312-9. Epub 2005 Mar 1.

23.

Apolipoprotein B100 metabolism in autosomal-dominant hypercholesterolemia related to mutations in PCSK9.

Ouguerram K, Chetiveaux M, Zair Y, Costet P, Abifadel M, Varret M, Boileau C, Magot T, Krempf M.

Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):1448-53. Epub 2004 May 27.

PMID:
15166014
24.

New model for kinetic studies of HDL metabolism in humans.

Chétiveaux M, Ouguerram K, Zair Y, Maugère P, Falconi I, Nazih H, Krempf M.

Eur J Clin Invest. 2004 Apr;34(4):262-7.

PMID:
15086357
25.
26.

Insulin effects on acetate metabolism.

Piloquet H, Ferchaud-Roucher V, Duengler F, Zair Y, Maugere P, Krempf M.

Am J Physiol Endocrinol Metab. 2003 Sep;285(3):E561-5. Epub 2003 May 28.

27.

Effect of atorvastatin on apolipoprotein B100 containing lipoprotein metabolism in type-2 diabetes.

Ouguerram K, Magot T, Zaïr Y, Marchini JS, Charbonnel B, Laouenan H, Krempf M.

J Pharmacol Exp Ther. 2003 Jul;306(1):332-7. Epub 2003 Apr 8.

PMID:
12684543
28.

Apolipoprotein E kinetics: influence of insulin resistance and type 2 diabetes.

Bach-Ngohou K, Ouguerram K, Nazih H, Maugère P, Ripolles-Piquer B, Zaïr Y, Frénais R, Krempf M, Bard JM.

Int J Obes Relat Metab Disord. 2002 Nov;26(11):1451-8.

PMID:
12439646
29.

The differential apoA-I enrichment of prebeta1 and alphaHDL is detectable by gel filtration separation.

Chétiveaux M, Nazih H, Ferchaud-Roucher V, Lambert G, Zaïr Y, Masson M, Ouguerram K, Bouhours D, Krempf M.

J Lipid Res. 2002 Nov;43(11):1986-93.

30.

Negative and independent influence of apolipoprotein E on C-reactive protein (CRP) concentration in obese adults. Potential anti-inflammatory role of apoE in vivo.

Bach-Ngohou K, Nazih H, Nazih-Sanderson F, Zaïr Y, Le Carrer D, Krempf M, Bard JM.

Int J Obes Relat Metab Disord. 2001 Dec;25(12):1752-8.

PMID:
11781754
31.

Effect of low-density lipoproteins on apolipoprotein AI kinetics in heterozygous familial hypercholesterolemia.

Frénais R, Maugeais C, Ouguerram K, Zaïr Y, Bard JM, Charbonnel B, Magot T, Krempf M.

Metabolism. 2001 Jun;50(6):635-9.

PMID:
11398137
32.

In vivo evidence for the role of lipoprotein lipase activity in the regulation of apolipoprotein AI metabolism: a kinetic study in control subjects and patients with type II diabetes mellitus.

Frénais R, Nazih H, Ouguerram K, Maugeais C, Zaïr Y, Bard JM, Charbonnel B, Magot T, Krempf M.

J Clin Endocrinol Metab. 2001 May;86(5):1962-7.

PMID:
11344192

Supplemental Content

Support Center